Parker Paul Gray
SEC insider (Form 3/4/5 filer). CIK 0001833033. Director at Generate Biomedicines, Inc. (GENB) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 26, 2026. Located in SOMERVILLE, MA.
Companies Parker Paul Gray has filed insider reports for
- Generate Biomedicines, Inc. (GENB): Director
- CLOROX CO /DE/ (CLX): Director
Parker Paul Gray
CIK: 0001833033
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
